The next step towards the elimination of iodine deficiency and preventable iodine-related disorders in Europe

Informazioni relative al progetto

EUthyroid2

ID dell’accordo di sovvenzione: 101095643

DOI

10.3030/101095643

Data della firma CE 25 Novembre 2022

Data di avvio 1 Gennaio 2023

Data di completamento 31 Dicembre 2026

Finanziato da

• Health

Costo totale

€ 2 567 165,00

Contributo UE

€ 2 567 165,00

Coordinato da

UNIVERSITATSMEDIZIN GREIFSWALD KORPERSCHAFT DES OFFENTLICHEN RECHTS
Germany

Periodic Reporting for period 1 - EUthyroid2 (The next step towards the elimination of iodine deficiency and preventable iodine-related disorders in Europe)

Periodo di rendicontazione: 2023-01-01 al 2024-06-30

Sintesi del contesto e degli obiettivi generali del progetto

Iodine deficiency is the world’s leading cause of thyroid disorders and the single most important and preventable cause of brain damage. For women getting pregnant, even mild-to-moderate ID during pregnancy is related to neurocognitive impairment in the offspring. Therefore, EUthyroid as an EU-funded public health consortium targets the elimination of iodine deficiency and related preventable disorders in Europe.
After uncovering low awareness on the importance of iodine for healthy living within the frame of EUthyroid, the main objective of EUthyroid2 is to fill important gaps in the prevention of iodine deficiency in Europe and beyond.
An important step is the improvement of that low awareness with respect to iodine-related risks in adolescents and young woman. For this purpose, implementation studies and community-based randomized-controlled trials will be conducted with interventions performed in the educational system and ambulatory care in eight study regions.
By finding the best practice models, EUthyroid2 will lay the foundation for a cost-effective way to eradicate iodine deficiency-related disorders.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

There will be two intervention studies in the EUthyroid2 project with the objective of increasing IDD-related awareness in adolescents and young women up to age of 24 before pregnancy.
The instruments were developed for both interventions (ambulatory care setting and educational setting) and adapted or edited to take account of cultural differences in the respective study regions. Questionnaires were developed to measure success. The intervention instruments and the data collection instruments were translated into the respective national languages and tested. This process has not yet been completed for all study regions, but is in the final stages so that the roll-out can begin shortly. The infrastructure for centralised data collection has been created.
A manuscript on the study design has been drafted and is currently being reviewed by the co-authors.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

So far, all intervention tools have been developed but not yet used, so that no results regarding their effectiveness are available at this time